Women whose Fallopian tubes are removed during sterilization via laparoscopy have only marginally more surgical complications than those whose tubes are simply cut, a study shows.
Ginkgo Bioworks handed a DARPA manufacturing contract; Merck hits a primary endpoint for Keytruda in first-line cervical cancer
The Defense Advanced Research Projects Agency (DARPA) is giving Ginkgo Bioworks a 4-year contract worth up to $18 million, to manufacture complex therapeutic proteins. Ginkgo
July 20, 2023